Revision history of "Knowledge transfer in clinical applications of biogenomics in oncology and related fields – BIOGENONCO" (Q3100455)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 10:0110:01, 8 October 2024DG Regio talk contribs 57,183 bytes +6 Changed label, description and/or aliases in pt
  • curprev 10:0110:01, 8 October 2024DG Regio talk contribs 57,177 bytes +18 Set a claim value: summary (P836): O objetivo do projeto é desenvolver, através da transferência de conhecimento, em parceria com um mínimo de 10 empresas, produtos e serviços novos/melhorados e inovadores, procurados pelo mercado, derivados através de aplicações práticas da biogenómica em oncologia, num período de 72 meses. O efeito positivo a longo prazo é aumentar a qualidade dos cuidados de saúde para o doente oncológico e aumentar a rentabilidade do mercado das empresas parceira...

22 March 2024

19 June 2023

11 June 2023

21 February 2023

4 August 2022

  • curprev 00:0100:01, 4 August 2022DG Regio talk contribs 57,919 bytes +34,983 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, sv, nl, fr, de, it, ro, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, sv,

13 January 2022

12 January 2022

15 December 2021

6 December 2021

1 December 2021

  • curprev 08:4808:48, 1 December 2021DG Regio talk contribs 17,107 bytes +1,766 Created claim: summary (P836): Ziel des Projekts ist es, durch Wissenstransfer in Partnerschaft mit mindestens 10 Unternehmen innerhalb von 72 Monaten neue/verbesserte, innovative Produkte und Dienstleistungen zu entwickeln, die vom Markt gefordert werden und durch praktische Anwendungen der Biogenomik in der Onkologie abgeleitet werden. Der langfristige positive Effekt besteht darin, die Qualität der Gesundheitsversorgung für den Krebspatienten zu erhöhen und die Marktrentab...
  • curprev 08:4808:48, 1 December 2021DG Regio talk contribs 15,341 bytes +170 Changed label, description and/or aliases in de: translated_label

27 November 2021

  • curprev 15:3015:30, 27 November 2021DG Regio talk contribs 15,171 bytes +1,779 Created claim: summary (P836): L’objectif du projet est de développer, par le transfert de connaissances, en partenariat avec un minimum de 10 entreprises, des produits et services nouveaux/améliorés et innovants, exigés par le marché, issus d’applications pratiques de la biogénomique en oncologie, dans une période de 72 mois. L’effet positif à long terme est d’améliorer la qualité des soins de santé pour les patients atteints de cancer et d’accroître la rentabilité du marché...
  • curprev 15:2915:29, 27 November 2021DG Regio talk contribs 13,392 bytes +196 Changed label, description and/or aliases in fr: translated_label

10 October 2021

8 October 2021

6 October 2021

5 October 2021

27 September 2021

23 September 2021

16 September 2021

  • curprev 10:5710:57, 16 September 2021DG Regio talk contribs 11,404 bytes +164 Changed label, description and/or aliases in en: translated_label
  • curprev 10:5710:57, 16 September 2021DG Regio talk contribs 11,240 bytes +1,642 Created claim: summary (P836): The objective of the project is to develop, through knowledge transfer, in partnership with a minimum of 10 companies, new/improved, innovative products and services, demanded by the market, derived through practical applications of biogenomics in oncology, in a period of 72 months. The long-term positive effect is to increase the quality of healthcare for the cancer patient and to increase the market profitability of partner companies. Cancer i...

14 September 2021